NEW YORK (GenomeWeb News) – Millennium Laboratories said today that it has acquired healthcare predictive analytics and decision support firm RxAnte.

RxAnte, a venture-backed startup, markets products to help health plans, pharmacy-benefit management companies, pharmacy chains, and healthcare providers improve patient adherence to treatments. Millennium, meanwhile, offers pharmacogenetic testing for pain treatment, substance abuse disorders, psychiatric conditions, and various chronic diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcripts, and more.

While James Watson and Francis Crick are credited for discovering the structure of DNA, Rich proved their theory of a double helix structure was correct when he produced a distinct image of the structure.

Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses. 

According to MIT Technology Review, Apple is collaborating with researchers to develop apps for consumer DNA testing.